ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
OP
Orion Pharma at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Orion Pharma takes part in 2 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1047. Its research focuses on experimental cancer treatments across solid tumours. The studies assess a dual-target antibody in mouse tumour models and evaluate ODM-212 in human cancers.
| Organization | ESMO 2026 Attendance |
|---|---|
OP Orion Pharma | |
Finnish pharmaceutical company that co-developed the prostate cancer drug darolutamide with Bayer. | Booth Exhibiting at Booth 1047 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 |
Find decision makers at Orion Pharma
Tell us what you sell and we’ll find the people at Orion Pharma most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction